A Phase II, Multicenter, Randomized, Placebo -Controlled, Study To Evaluate The Efficacy and Safety Of Intramuscular Peramivir 600 mg In Subjects With Uncomplicated Acute Influenza

Status:
Completed

Trial end date:
2009-10-01

Target enrollment:

Participant gender:

The purpose of this study is to determine whether peramivir is safe and effective in the treatment of uncomplicated seasonal influenza.

Phase 2

BioCryst Pharmaceuticals

Peramivir